Abstract
purpose. To determine the most effective objective tests, applied singly or in combination in the diagnosis of dry eye disease.
methods. Two groups of subjects—41 with dry eye and 32 with no ocular surface disease—had symptoms, tear film quality, evaporation, tear turnover rate (TTR), volume and osmolarity, and meibomian gland dropout score assessed.
results. The subjects with dry eye had TTR, tear evaporation, and osmolarity significantly different from that of healthy normal subjects. Cutoff values between the groups were determined from distribution curves for each aspect of tear physiology, and the effectiveness of the cutoff was determined from receiver operator characteristic (ROC) curves. Values of 12%/min for TTR, 33 g/m−2/h for evaporation, and 317 mOsmol/L for osmolarity were found to give sensitivities, specificities, and overall accuracies of 80%, 72%, and 77%; 51%, 96%, and 67%; and 78, 78%, and 79%, respectively when applied singly as diagnostic criteria in dry eye. In combination, they yielded sensitivities, specificities, and overall accuracy of 100%, 66%, and 86% (in parallel) and 38%, 100%, and 63% (in series), respectively. Discriminant function analysis incorporating these three factors in an equation allowed diagnosis with a sensitivity of 93%, specificity of 88%, and overall accuracy of 89%.
conclusions. Tear osmolarity is the best single test for the diagnosis of dry eye, whereas a battery of tests employing a weighted comparison of TTR, evaporation, and osmolarity measurements derived from discriminant function analysis is the most effective.
Attempts have been made to define the condition of dry eye,
1 but the methods for its diagnosis vary widely, undermining attempts at definition by the use of differing diagnostic criteria and creating difficulties in comparisons of prevalence and efficacy of treatment regimens. Diagnosis of dry eye disease is made difficult by its multifactorial etiology, by the need for a comprehensive definition, and by the use of tests that are limited and variable in their assessment of the tears and the ocular surface.
Some studies have used reports of symptoms as the criterion for the diagnosis of dry eye
2 3 4 5 6 7 8 (see
Table 1 ). It has been suggested that it is appropriate to diagnose dry eye from symptoms alone, as the condition rarely progresses to the stage of causing ocular discomfort without symptoms.
9 However, symptoms alone are inadequate for differential diagnosis of dry eye, because the same symptoms can be experienced with a range of ocular surface conditions and tear film disorders.
1 10
The most common objective diagnostic test for dry eye, the Schirmer test, which has been in use for more than 100 years,
11 lacks standardization,
12 is inaccurate and unrepeatable because of the reflex secretion produced by its invasive nature,
13 and measures tear production only,
14 so that the evaporative aspects of dry eye are overlooked.
12 However, the low cost of strips, their ease of application, and the lack of availability of a more acceptable diagnostic test has led to the Schirmer test’s being the most commonly applied clinical test for lacrimal secretary function in dry eye.
15
Tear break-up time (TBUT) measurement with fluorescein is another widely used technique for dry eye diagnosis by clinicians. This test is considered to be more reliable than the Schirmer test, as it is repeatable
16 and minimally invasive; however, the instillation of fluorescein can destabilize the tear film.
17 18 The measurement of break up time in the absence of fluorescein (NIBUT) can overcome this problem and give a more accurate assessment of tear stability. But all forms of tear break-up measurement fail to give direct information on tear evaporation.
12
Ocular surface staining with vital dyes such as rose bengal, lissamine green, and fluorescein have also been used to diagnose dry eye.
19 20 21 The disadvantage of these tests is that dry eye is measured by the extent of ocular surface damage, and therefore do not necessarily detect early dry eye or differentiate dry eye from other conditions causing ocular surface staining.
22
Tear physiology tests can also be used to diagnose dry eye. Normal tear film dynamics require adequate production, retention on the ocular surface, and balanced elimination.
23 The quantitative aspects of tear dynamics include distribution, turnover (and drainage), evaporation, and absorption of the tears. An imbalance in any of these components would disrupt the normal tear physiology and lead to dry eye. The proportion of ocular surface absorption of a dye in eyes with normal corneas has been shown to be minimal at only 0.24% ± 0.13%.
24 Therefore, the contribution of tear absorption to the overall tear elimination can be said to be negligible. Tear osmolarity represents the end product of changes in tear dynamics
25 and is thought to be an attractive index for dry eye diagnosis.
26 Direct measurements of tear production, stability, evaporation and osmolarity have the potential to be accurate and sensitive tests for dry eye, and these are the tests assessed in this study.
It has been shown that there is poor correlation between symptoms and signs of dry eye. Only 57% of the symptomatic patients have been shown to have objective signs of dry eye.
9 10 27 28 29 This finding has been attributed to the symptoms preceding the signs, or the differing etiology and pathophysiology of dry eye.
30 Also, a single objective test for dry eye is of limited value without a report of symptoms.
9
A large number of tests have been used singly, or in combination, to diagnose the condition with variable success,
13 17 23 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 (Table 1) , because of the inherent variability of most tests and their inability to measure specifically the change in tear physiology in the multifactorial condition of dry eye.
10
The purpose of this study was to assess as directly as possible tear physiology and meibomian gland function in a range of dry eye conditions in an attempt to optimize the diagnosis by determining the most suitable single test or battery of diagnostic tests. The study complied with the guidelines in the Declaration of Helsinki for research involving human subjects. All participants provided signed informed consent.
Two groups of subjects were recruited for the study, including those with dry eye and normal subjects with no symptoms or signs of anterior eye disease. Patients with dry eye were referred from two Glasgow hospitals to the Tear Physiology Unit in Glasgow Caledonian University for tear evaluation. Clinical diagnosis of dry eye was made by the referring ophthalmologists (KR, CD) on the basis of symptoms, clinical observations, Schirmer I test, tear break-up time, and autoantibody tests (in the case of Sjögren’s syndrome). All the patients had positive dry eye symptoms. Patients treated with tear supplementation were instructed not to use any solutions for 48 hours before tear evaluation. The dry eye group was made up of patients defined by the ophthalmologists in the following subgroups: Sjögren’s syndrome, graft-versus-host disease (GVHD), or the general category other dry eye. Patients with blepharitis were excluded from the study.
Normal subjects were recruited initially by a general e-mail notice within the university. The inclusion criteria for normal subjects were less than two symptoms on the McMonnies Dry Eye Questionnaire,
32 noninvasive tear break-up time (NIBUT)
48 of greater than 10 seconds, and a Schirmer I test score
11 13 14 of >5 mm in 5 minutes. Subjects who had worn contact lenses and those with external ocular diseases in the previous 6 months were excluded from the study. None of the normal subjects had ever used tear supplements before. Signed consent was obtained from all the subjects and patients before recruitment into the study.
All the measured variables were tested for normality. Tear evaporation, turnover rate, osmolarity, and volume were normally distributed. A two-sampled t-test showed that there were statistically significant differences between normal subjects and patients with dry eye for tear turnover rate (TTR; P < 0.001), tear evaporation (P = 0.001), and osmolarity (P < 0.001), but not for tear volume (P = 0.234). The frequency distribution of tear film quality grade was determined by χ2 test, and no significant difference was seen between the groups (P = 0.717). The distribution of meibomian gland dropout score was not normal, and so a nonparametric test (Mann-Whitney U test) was used to test for significant differences between the subject groups. No significant difference was seen in the mean meibomian gland dropout scores (P = 0.691) between normal subjects and patients with dry eye. Abnormal meibomian gland function (meibomian gland dropout score ≥ 2), was present in 14% of normal subjects and 20.4% of patients with dry eye.
As significant differences had been demonstrated for tear turnover, evaporation, and osmolarity between normal subjects and those with and dry eye, the use of these aspects of tear physiology were assessed for their effectiveness in diagnosis.
Distribution curves of TTR, evaporation, and osmolarity were plotted for normal subjects and patients with dry eye. As an example, the values for TTR are shown in
Figure 1 .